Alec Redwood

12PUBLICATIONS
36CO-AUTHORS
Molecular targetsGenetically modified animalsImmunogenetics (incl. genetic immunology)TransgenesisAgricultural molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 28, 2026
Hidden Targets in Cancer Immunotherapy: The Potential of "Dark Matter" Neoantigens.

Francois Xavier Rwandamuriye, Alec J Redwood, Jenette Creaney

|Nov 12, 2024
Fine-tuning the evolutionary stability of recombinant herpesviral transmissible vaccines.

Baca Chan, Scott L Nuismer, Hujaz Alqirbi

|Nov 01, 2023
Computational immunogenomic approaches to predict response to cancer immunotherapies.

Venkateswar Addala, Felicity Newell, John V Pearson

|Feb 21, 2022
What's next in cancer immunotherapy? - The promise and challenges of neoantigen vaccination.

Alec J Redwood, Ian M Dick, Jenette Creaney

|Jan 20, 2022
Quantifying the effectiveness of betaherpesvirus-vectored transmissible vaccines.

Tanner J Varrelman, Christopher H Remien, Andrew J Basinski

|Oct 29, 2021
Methods for measuring the evolutionary stability of engineered genomes to improve their longevity.

Scott L Nuismer, Nathan C Layman, Alec J Redwood

Pageof 2